The fatal contribution of serine protease-related genetic variants to COVID-19 outcomes.

Abstract

Introduction:

Serine proteases play a critical role during SARS-CoV-2 infection. Therefore, polymorphisms of transmembrane protease serine 2 (TMPRSS2) and serpine family E member 1 (SERPINE1) could help to elucidate the contribution of variability to COVID-19 outcomes.

Methods:

To evaluate the genetic variants of the genes previously associated with COVID-19 outcomes, we performed a cross-sectional study in which 1536 SARS-CoV-2-positive participants were enrolled. TMPRSS2 (rs2070788, rs75603675, rs12329760) and SERPINE1 (rs2227631, rs2227667, rs2070682, rs2227692) were genotyped using the Open Array Platform. The association of polymorphisms with disease outcomes was determined by logistic regression analysis adjusted for covariates (age, sex, hypertension, type 2 diabetes, and obesity).

Results:

According to our codominant model, the GA genotype of rs2227667 (OR=0.55; 95% CI = 0.36-0.84; p=0.006) and the AG genotype of rs2227667 (OR=0.59; 95% CI = 0.38-0.91; p=0.02) of SERPINE1 played a protective role against disease. However, the rs2227692 T allele and TT genotype SERPINE1 (OR=1.45; 95% CI = 1.11-1.91; p=0.006; OR=2.08; 95% CI = 1.22-3.57; p=0.007; respectively) were associated with a decreased risk of death. Similarly, the rs75603675 AA genotype TMPRSS2 had an OR of 1.97 (95% CI = 1.07-3.6; p=0.03) for deceased patients. Finally, the rs2227692 T allele SERPINE1 was associated with increased D-dimer levels (OR=1.24; 95% CI = 1.03-1.48; p=0.02).

Discussion:

Our data suggest that the rs75603675 TMPRSS2 and rs2227692 SERPINE1 polymorphisms are associated with a poor outcome. Additionally, rs2227692 SERPINE1 could participate in hypercoagulable conditions in critical COVID-19 patients, and this genetic variant could contribute to the identification of new pharmacological targets and treatment strategies to block the inhibition of TMPRSS2 entry into SARS-CoV-2.

• Authors: Laura Edith Martínez-Gómez, Carlos Martinez-Armenta, Teresa Tusie-Luna, Paola Vázquez-Cárdenas, Rosa P Vidal-Vázquez, Juan P Ramírez-Hinojosa, Diana Gómez-Martín, Gilberto Vargas-Alarcón, Rosalinda Posadas-Sánchez, José Manuel Fragoso, Aurora de la Peña, José Manuel Rodríguez-Pérez, Mónica M Mata-Miranda, Gustavo J Vázquez-Zapién, Adriana Martínez-Cuazitl, Felipe de J Martínez-Ruiz, Dulce M Zayago-Angeles, Luis Ramos-Tavera, Alberto Méndez-Aguilera, María Del C Camacho-Rea, María L Ordoñez-Sánchez, Yayoi Segura-Kato, Carlos Suarez-Ahedo, Jessel Olea-Torres, Brígida Herrera-López, Carlos Pineda, Gabriela A Martínez-Nava, Alberto López-Reyes
• Journal: Frontiers in immunology (Front Immunol) Vol. 15 Pg. 1335963 ( 2024) ISSN: 1664-3224 [Electronic] Switzerland
• PMID: 38601158 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2024 Martínez-Gómez, Martinez-Armenta, Tusie-Luna, Vázquez-Cárdenas, Vidal-Vázquez, Ramírez-Hinojosa, Gómez-Martín, Vargas-Alarcón, Posadas-Sánchez, Fragoso, de la Peña, Rodríguez-Pérez, Mata-Miranda, Vázquez-Zapién, Martínez-Cuazitl, Martínez-Ruiz, Zayago-Angeles, Ramos-Tavera, Méndez-Aguilera, Camacho-Rea, Ordoñez-Sánchez, Segura-Kato, Suarez-Ahedo, Olea-Torres, Herrera-López, Pineda, Martínez-Nava and López-Reyes.

Chemical References

• Serine Proteases

Topics

• Humans
• COVID-19 (genetics)
• Serine Proteases
• SARS-CoV-2
• Diabetes Mellitus, Type 2
• Cross-Sectional Studies